NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies

A Contract Award Notice
by THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)

Source
OJEU
Type
Framework (Supply)
Duration
1 year (est.)
Value
£644M
Sector
HEALTH
Published
26 Feb 2021
Delivery
01 Mar 2021 to 28 Feb 2022 (est.)
Deadline
n/a

Concepts

Location

Please refer to document No 10 for a full list of participating authorities

Geochart for 2 buyers and 56 suppliers

2 buyers

37 suppliers

Description

CM/PHR/20/5591/01 — Midlands and East, Branded Medicines – Tranche B. Period of framework: 1 March 2021 to 28 February 2023 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months CM/PHR/20/5591/02 — Midlands and East Branded Medicines – Annual Tranche, Cytokine Modulators, other monoclonal antibodies Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma. Period of framework: 1 March 2021 to 28 February 2022 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months CM/PHR/20/5591/03 – Supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to Pan London. Period of framework: 1 March 2021 to 31 August 2021 CM/PHR/20/5591/04 – Supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to South of England. Period of framework: 1 March 2021 to 31 August 2021.

Lot Division

1 Midlands and East (MAE) Tranche B

CM/PHR/20/5591/01 — NHS Framework for the Midlands and East, Branded Medicines – Tranche B. Period of framework: 1 March 2021 to 28 February 2023 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
2 Midlands and East Cytokine Modulators and other Monoclonal Antibodies

CM/PHR/20/5591/02 — NHS Framework for the Midlands and East Branded Medicines – Annual Tranche, Cytokine Modulators, other monoclonal antibodies Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma. Period of framework: 1 March 2021 to 28 February 2022 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.
3 LNW) – Interleukin Inhibitors, JAK Inhibitors, Migraine and Asthma

CM/PHR/20/5591/03 – NHS Framework agreement for the supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to Pan London.
4 SOFE) – Interleukin Inhibitors, JAK Inhibitors, Migraine and Asthma

CM/PHR/20/5591/04 – NHS framework agreement for the supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to South of England.

Award Detail

1 Accord (Barnstaple)
  • Num offers: 30
  • Value: £1
2 Aventis Pharma (Reading)
  • Num offers: 30
  • Value: £1
3 Bayer (Reading)
  • Num offers: 30
  • Value: £1
4 Biogen (Maidenhead)
  • Num offers: 30
  • Value: £1
5 Bristol Myers Squibb (Uxbridge)
  • Num offers: 30
  • Value: £1
6 Celltrion Healthcare (Slough)
  • Num offers: 30
  • Value: £1
7 CST Pharma (Walsall)
  • Num offers: 30
  • Value: £1
  • Contractor is an SME.
8 Daiichi Sankyo (Uxbridge)
  • Num offers: 30
  • Value: £1
  • Contractor is an SME.
9 Day Lewis Medical (Croydon)
  • Num offers: 30
  • Value: £1
10 Drreddys Laboratories (Beverley)
  • Num offers: 30
  • Value: £1
  • Contractor is an SME.
11 Eli Lilly (Basingstoke)
  • Num offers: 30
  • Value: £1
12 Leo Pharma (Hurley)
  • Num offers: 30
  • Value: £1
13 Ferring Pharmaceuticals (West Drayton)
  • Num offers: 30
  • Value: £1
  • Contractor is an SME.
14 Gilead Sciences (London)
  • Num offers: 30
  • Value: £1
15 Ipsen (Slough)
  • Num offers: 30
  • Value: £1
16 Merck Serono (Feltham)
  • Num offers: 30
  • Value: £1
17 Merck Sharpe & Dohme (Hoddesdon)
  • Num offers: 30
  • Value: £1
18 Mylan (Potters Bar)
  • Num offers: 30
  • Value: £1
  • Contractor is an SME.
19 Napp Pharmaceuticals (Cambridge)
  • Num offers: 30
  • Value: £1
20 Novo Nordisk (Gatwick)
  • Num offers: 30
  • Value: £1
21 Roche Products (Welwyn Garden City)
  • Num offers: 30
  • Value: £1
  • Contractor is an SME.
22 Rovi Biotech (Croydon)
  • Num offers: 30
  • Value: £1
  • Contractor is an SME.
23 Novartis Pharmaceuticals (London)
  • Num offers: 30
  • Value: £1
24 Pfizer (Sandwich)
  • Num offers: 30
  • Value: £1
25 Sandoz (Surrey)
  • Num offers: 30
  • Value: £1
  • Contractor is an SME.
26 Techdow Pharma England (Guildford)
  • Num offers: 30
  • Value: £1
  • Contractor is an SME.
27 Takeda (London)
  • Num offers: 30
  • Value: £1
28 Teva (Castleford)
  • Num offers: 30
  • Value: £1
29 Ul Global Pharma (Watford)
  • Num offers: 30
  • Value: £1
  • Contractor is an SME.
30 Bristol Myers Squibb (Uxbridge)
  • Num offers: 20
  • Value: £1
31 Celltrion Healthcare (Slough)
  • Num offers: 20
  • Value: £1
32 Eli Lilly (Basingstoke)
  • Num offers: 20
  • Value: £1
33 Astrazeneca (Luton)
  • Num offers: 20
  • Value: £1
34 Merck Sharpe & Dohme (Hoddesdon)
  • Num offers: 20
  • Value: £1
35 Napp Pharmaceuticals (Cambridge)
  • Num offers: 20
  • Value: £1
36 Novartis Pharmaceuticals (London)
  • Num offers: 20
  • Value: £1
37 Pfizer (Sandwich)
  • Num offers: 20
  • Value: £1
38 Roche Products (Welwyn Garden City)
  • Num offers: 20
  • Value: £1
  • Contractor is an SME.
39 Teva (Castleford)
  • Num offers: 20
  • Value: £1
40 Takeda (London)
  • Num offers: 20
  • Value: £1
41 Amgen (Cambridge)
  • Num offers: 20
  • Value: £1
42 Gedeon Richter (London)
  • Num offers: 20
  • Value: £1
  • Contractor is an SME.
43 Thornton & Ross (Huddersfield)
  • Num offers: 20
  • Value: £1
44 Ucb Pharma (Slough)
  • Num offers: 20
  • Value: £1
45 Janssen Cilag (High Wycombe)
  • Num offers: 20
  • Value: £1
46 Merck Sharp & Dohme MSD (Hoddesdon)
  • Num offers: 20
  • Value: £1
47 Sobi Swedish Orphan Biovitrum (Cambridgeshire)
  • Num offers: 20
  • Value: £1
  • Contractor is an SME.
48 Eli Lilly (Basingstoke)
  • Num offers: 6
  • Value: £1
49 Astrazeneca (Luton)
  • Num offers: 6
  • Value: £1
50 Teva (Castleford)
  • Num offers: 6
  • Value: £1
51 Sobi Swedish Orphan Biovitrum (Cambridgeshire)
  • Num offers: 6
  • Value: £1
  • Contractor is an SME.
52 Eli Lilly (Basingstoke)
  • Num offers: 7
  • Value: £1
53 Novartis Pharmaceuticals (London)
  • Num offers: 7
  • Value: £1
54 Teva (Castleford)
  • Num offers: 7
  • Value: £1
55 Astrazeneca (Luton)
  • Num offers: 7
  • Value: £1
56 Sobi Swedish Orphan Biovitrum (Cambridgeshire)
  • Num offers: 7
  • Value: £1
  • Contractor is an SME.

Award Criteria

PRICE _

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Award on basis of price.

Other Information

Price is not the only award criterion and all criteria are stated only in the procurement documents.

Reference

Domains